Yet, recent advances in targeting non-surface tumor antigens lead to the emergence of T cell receptor mimics (TCRm) CAR-T-cells, capable of recognizing peptide/MHC complexes derived from tumor-antigens [71]. Here, HLA-C is linked to neoplasm.